Skip to content

D&A at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$3.22M-7.9%
eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
$74.15K+5.2%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$714K-11.1%
Biote Corp. logo
Biote Corp.BTMD
$980K+14.4%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$12.34M-13.1%
USANA Health Sciences logo
USANA Health SciencesUSNA
$8.28M-0.7%

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's D&A?
NAGE (NAGE) reported D&A of $116K in Q1 2026.
How has NAGE's D&A changed year-over-year?
NAGE's D&A decreased by 26.6% year-over-year, from $158K to $116K.
What is the long-term trend for NAGE's D&A?
Over 3 years (2021 to 2025), NAGE's D&A has grown at a -11.7% compound annual growth rate (CAGR), from $890K to $612K.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.